Synonyms: ATB 346 | ATB-346 | ATB-346, (S)- | ATB346
Compound class:
Synthetic organic
Comment: Otenaproxesul (ATB-346) is a novel, orally administered, gastrointestinal-sparing hydrogen sulfide (H2S)-releasing analgesic and anti-inflammatory drug in clinical trials for osteoarthritis [8]. Structurally it comprises an H2S-releasing moiety covalently linked to a NSAID (naproxen). H2S-releasing NSAIDs are in development for their potential analgesic, anti-inflammatory, cytoprotective and chemopreventative properties [2-3,5-6,9-10].
|
|
Classification | |
Compound class | Synthetic organic |
Ligand families/groups | Non-steroidal anti-inflammatory ligands |
International Nonproprietary Names | |
INN number | INN |
11059 | otenaproxesul |
Synonyms |
ATB 346 | ATB-346 | ATB-346, (S)- | ATB346 |
Database Links | |
CAS Registry No. | 1000700-29-7 (source: WHO INN record) |
GtoPdb PubChem SID | 336446920 |
PubChem CID | 72941967 |
Search Google for chemical match using the InChIKey | YCNMAPLPQYQJFC-ZDUSSCGKSA-N |
Search Google for chemicals with the same backbone | YCNMAPLPQYQJFC |
Search PubMed clinical trials | otenaproxesul |
Search PubMed titles | otenaproxesul |
Search PubMed titles/abstracts | otenaproxesul |
UniChem Compound Search for chemical match using the InChIKey | YCNMAPLPQYQJFC-ZDUSSCGKSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YCNMAPLPQYQJFC-ZDUSSCGKSA-N |